Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer
Open Access
- 24 January 2013
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 16
Abstract
Background: The purpose of this study was to investigate the anti-tumor effect and explore the mechanisms of celecoxib (a selective cyclooxygenase-2 inhibitor) combined with 5-fluorouracil (5-FU) on the treatment of human colorectal cancer in a BALB/C nude mouse subcutaneous xenograft model.Methods: Effects of celecoxib combined with 5-FU on the proliferation of xenograft carcinoma induced by HT-29 were investigated. The apoptotic cells were detected by electron microscope and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay. Immunohistochemistry and Western blot were used to estimate the expression of cytochrome C, caspase-3 and caspase-9.Results: Compared with the control group, treatment groups showed significant inhibition of tumor growth. More apoptotic cells existed after treatment with celecoxib combined with 5-FU. Cytochrome C, caspase-3 and caspase-9 were increased in treated groups, and more obviously in the drug combination group. Cyclooxygenase-2 (COX-2) were decreased after treatment with celecoxib only or combined with 5-FU. And the combined group showed a greater decrease.Conclusions: Celecoxib combined with 5-FU could inhibit the growth of tumorsin vivoby inducing apoptosis and activation of the cytochrome C dependency apoptosis signal pathway. A decrease of COX-2 and an increase of cytochrome C, caspase-3 and caspase-9 may be involved in this process.Keywords
This publication has 28 references indexed in Scilit:
- Cyclooxygenase as a Target for Colorectal Cancer ChemopreventionCurrent Drug Targets, 2011
- DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cellsCancer Biology & Therapy, 2011
- Celecoxib reduces fluidity and decreases metastatic potential of colon cancer cell lines irrespective of COX-2 expressionBioscience Reports, 2011
- Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patientsAnnals of Oncology, 2011
- Absorption and Distribution Characteristics of 5-Fluorouracil (5-FU) after an Application to the Liver Surface in Rats in Order to Reduce Systemic Side EffectsBiological and Pharmaceutical Bulletin, 2008
- Celecoxib‐induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase GMolecular Carcinogenesis, 2007
- Synergistic antitumor effects of celecoxib with 5‐fluorouracil depend on IFN‐γInternational Journal of Cancer, 2007
- Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cellsWorld Journal of Gastroenterology, 2007
- Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experienceWorld Journal of Gastroenterology, 2006
- Activation of apoptosis pathways by anticancer treatmentToxicology Letters, 2000